National Guideline Clearinghouse | Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism.
National Institute for Health and Care Excellence (NICE)
Guideline Title
Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism.
Bibliographic Source(s)
National Institute for Health and Care Excellence (NICE). Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism. London (UK): National Institute for Health and Care Excellence (NICE); 2014 Dec. 49 p. (Technology appraisal guidance; no. 327). |
No hay comentarios:
Publicar un comentario